Pay in 4 interest-free payments of $5.95 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
Individuals with type 2 diabetes for blood sugar control Patients needing assistance with weight loss when diet and exercise are insufficient Adults with obesity (BMI 30) or overweight (BMI 27) with at least one weight-related condition (e.g., hypertension, type 2 diabetes, dyslipidemia) As mentioned, studies indicate that GLP-1 is most effective when combined with changes to diet and exercise
Exendin(9-39) was then added to block further surface receptor binding
Important insights
Improvements in blood sugar regulation, sustained weight loss, and enhanced metabolic health all contribute to a better quality of life and reduced risk of chronic diseases
American healthcare giant Eli Lillys rival injection, Zepbound, has gained rapid market share through aggressive marketing efforts
US$ 28.15
US$ 24.90
US$ 26.78
US$ 20.33
